Interv Akut Kardiol. 2018;17(2):82-84 | DOI: 10.36290/kar.2018.042

Catheter ablation of atrial fibrillation in heart failure patients

Luděk Haman
1. interní kardioangiologická klinika, Fakultní nemocnice v Hradci Králové
a Univerzita Karlova v Praze, Lékařská fakulta v Hradci Králové

Atrial fibrillation is an underappreciated reversible cause of left ventricular systolic dysfunction despite adequate rate control. Therestoration of sinus rhythm with catheter ablation results in an improvement in the ventricular function and is associated withlower rates of death and hospital admission for heart failure. These outcomes challenge the current treatment paradigm that ratecontrol is the appropriate strategy in patients with atrial fibrillation and heart failure.

Keywords: atrial fibrillation, catheter ablation, heart failure

Published: May 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Haman L. Catheter ablation of atrial fibrillation in heart failure patients. Interv Akut Kardiol. 2018;17(2):82-84. doi: 10.36290/kar.2018.042.
Download citation

References

  1. Čihák R, Haman L, Táborský M. ESC Guidelines for the mangement of atrial fibrillation developed in collaboration with EACTS. Summary of the document prepared by the Czech Society of Cardiology. Cor et Vasa 2016; 58: e636-e683. Go to original source...
  2. Santhanakrishnan R, Wang N, Larson MG, et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation 2016; 133: 484-492. Go to original source... Go to PubMed...
  3. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358: 2667-2677. Go to original source... Go to PubMed...
  4. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol 2014; 7: 31-38. Go to original source... Go to PubMed...
  5. Prabhu S, Taylor AJ, Costello BT, et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol 2017; 70: 1949-1961. Go to original source... Go to PubMed...
  6. Di Biase L, Mohanty P, Mohanty S, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation 2016; 133: 1637-1644. Go to original source... Go to PubMed...
  7. Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018; 378: 417-427. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.